KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Interest Expenses (2016 - 2025)

Bausch Health Companies' Interest Expenses history spans 17 years, with the latest figure at $397.0 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 17.8% year-over-year to $397.0 million; the TTM value through Dec 2025 reached $1.6 billion, up 15.56%, while the annual FY2025 figure was $1.6 billion, 15.56% up from the prior year.
  • Interest Expenses for Q4 2025 was $397.0 million at Bausch Health Companies, down from $412.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $465.0 million in Q2 2025 and bottomed at $307.0 million in Q4 2022.
  • The 5-year median for Interest Expenses is $353.0 million (2021), against an average of $360.5 million.
  • The largest annual shift saw Interest Expenses fell 22.2% in 2023 before it skyrocketed 32.86% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $343.0 million in 2021, then fell by 10.5% to $307.0 million in 2022, then grew by 18.24% to $363.0 million in 2023, then dropped by 7.16% to $337.0 million in 2024, then grew by 17.8% to $397.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Interest Expenses are $397.0 million (Q4 2025), $412.0 million (Q3 2025), and $465.0 million (Q2 2025).